CB2受体的配体
英文名 | BML-190 | CAS号 | 2854-32-2 |
试剂别名 |
2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-1-morpholinoethanone;BML-190;2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]-1-morpholin-4-ylethanone;BML 190;Ethanone,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(4-morpholinyl)-;IMMA;2-Methyl-5-methoxy-3-indolyl-essigsaeure-amid;Ethanone (2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(4-morpholinyl);Indomethacin morpholinamide;Indomethacin Morpholinylamide;Lopac-I-151;Tocris-1383;2-[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(4-morpholinyl)ethanone;1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-3-[2-(4-morpholinyl)-2-oxoethyl]-1H-indole;1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-[(morpholinocarbonyl)methyl]-indole
|
分子式 | C23H23ClN2O4 |
产品编号 | APEB1425 | 分子量 | 426.89 |
MDL号 | MFCD01317813 |
产品名称: | CB2受体的配体 |
英文名称: | BML-190 |
英文别名: | 2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-1-morpholinoethanone;BML-190;2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]-1-morpholin-4-ylethanone;BML 190;Ethanone,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(4-morpholinyl)-;IMMA;2-Methyl-5-methoxy-3-indolyl-essigsaeure-amid;Ethanone (2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(4-morpholinyl);Indomethacin morpholinamide;Indomethacin Morpholinylamide;Lopac-I-151;Tocris-1383;2-[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(4-morpholinyl)ethanone;1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-3-[2-(4-morpholinyl)-2-oxoethyl]-1H-indole;1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-[(morpholinocarbonyl)methyl]-indole |
中文别名: | 吲哚美辛吗啉代酰胺 |
CAS No.: | 2854-32-2 |
分子式: | C23H23CLN2O4 |
分子量: | 426.89 |
危险品级别: | |
HS符号: | |
危害声明: |